Digital Health Partnership Award open for applications in England

13

Jul 2021

On July 01, 2021, NHSX launched a new Digital Health Partnership Award. It will help NHS organizations receive funding to accelerate the adoption of digital health products and services to monitor patients with long-term conditions remotely.

The award will support technologies across the spectrum of development, from novel deployment to scaling proven technology.

Applications must be submitted by NHS organizations in England, identifying the technology, partnership stakeholders, and opportunity the proposals seek to support. The deadline for applications is July 31, 2021.

The following areas for the use of digital technologies are under the scope:

  • Optimization of care pathways, to scale existing services that support patients at home, in a care home, or closer to home with digital tools, to reach many more patients;
  • Patient-centred data exchange, data connectivity challenges where the solution will improve the interoperability of siloed solutions improving the long-term sustainable exchange of patient data for safe clinical care;
  • Self-management and prevention advice, integration of devices to improve the time in therapeutic range and the user experience for patients managing long-term conditions;
  • System efficiencies, digital solutions to support workforce management resources and capacity in remote care.

A key component of the application will be demonstrating how local, regional or national partnerships will deliver the rapid scale, deployment, and uptake of the digital solution. Partners can include other health and care organizations, higher education institutions, local authorities and commercial organizations, and others.

Applications will be assessed through an open and transparent process with an independent panel of healthcare professionals, alongside NHSX and NHS England and NHS Improvement senior stakeholders. Feedback for all applications and shortlist will be provided in August 2021.

There will be three categories of funding: projects requiring the support of up to £100,000, £250,000, and £500,000.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more